Preventing DCI in Patients After Subarachnoid Hemorrhage

The idea of targeting the pathways and thinking about clot formation and inflammation as really intertwined offers us an opportunity to rethink some of these drugs that work on clotting. And I think about how they may be beneficial, not just in clotting, but also in reducing inflammation. Okay, so I think we have a great segue now to talk about some of the trials in this field. Can you walk us through some of the recently completed ispasm clinical trials? Sure.